BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 27250935)

  • 1. Voxel Level Radiologic-Pathologic Validation of Restriction Spectrum Imaging Cellularity Index with Gleason Grade in Prostate Cancer.
    Yamin G; Schenker-Ahmed NM; Shabaik A; Adams D; Bartsch H; Kuperman J; White NS; Rakow-Penner RA; McCammack K; Parsons JK; Kane CJ; Dale AM; Karow DS
    Clin Cancer Res; 2016 Jun; 22(11):2668-74. PubMed ID: 27250935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRI-Derived Restriction Spectrum Imaging Cellularity Index is Associated with High Grade Prostate Cancer on Radical Prostatectomy Specimens.
    Liss MA; White NS; Parsons JK; Schenker-Ahmed NM; Rakow-Penner R; Kuperman JM; Bartsch H; Choi HW; Mattrey RF; Bradley WG; Shabaik A; Huang J; Margolis DJ; Raman SS; Marks LS; Kane CJ; Reiter RE; Dale AM; Karow DS
    Front Oncol; 2015; 5():30. PubMed ID: 25741473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restriction spectrum imaging improves MRI-based prostate cancer detection.
    McCammack KC; Schenker-Ahmed NM; White NS; Best SR; Marks RM; Heimbigner J; Kane CJ; Parsons JK; Kuperman JM; Bartsch H; Desikan RS; Rakow-Penner RA; Liss MA; Margolis DJ; Raman SS; Shabaik A; Dale AM; Karow DS
    Abdom Radiol (NY); 2016 May; 41(5):946-53. PubMed ID: 26910114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel technique for characterizing prostate cancer utilizing MRI restriction spectrum imaging: proof of principle and initial clinical experience with extraprostatic extension.
    Rakow-Penner RA; White NS; Parsons JK; Choi HW; Liss MA; Kuperman JM; Schenker-Ahmed N; Bartsch H; Mattrey RF; Bradley WG; Shabaik A; Huang J; Margolis DJ; Raman SS; Marks L; Kane CJ; Reiter RE; Karow DS; Dale AM
    Prostate Cancer Prostatic Dis; 2015 Mar; 18(1):81-5. PubMed ID: 25559097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo prostate cancer detection and grading using restriction spectrum imaging-MRI.
    McCammack KC; Kane CJ; Parsons JK; White NS; Schenker-Ahmed NM; Kuperman JM; Bartsch H; Desikan RS; Rakow-Penner RA; Adams D; Liss MA; Mattrey RF; Bradley WG; Margolis DJ; Raman SS; Shabaik A; Dale AM; Karow DS
    Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):168-73. PubMed ID: 26754261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology.
    Le JD; Tan N; Shkolyar E; Lu DY; Kwan L; Marks LS; Huang J; Margolis DJ; Raman SS; Reiter RE
    Eur Urol; 2015 Mar; 67(3):569-76. PubMed ID: 25257029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of prostate cancer index lesions with multiparametric magnetic resonance imaging (mp-MRI) using whole-mount histological sections as the reference standard.
    Russo F; Regge D; Armando E; Giannini V; Vignati A; Mazzetti S; Manfredi M; Bollito E; Correale L; Porpiglia F
    BJU Int; 2016 Jul; 118(1):84-94. PubMed ID: 26198404
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pre-biopsy 3-Tesla MRI and targeted biopsy of the index prostate cancer: correlation with robot-assisted radical prostatectomy.
    Patel U; Dasgupta P; Challacombe B; Cahill D; Brown C; Patel R; Kirby R
    BJU Int; 2017 Jan; 119(1):82-90. PubMed ID: 27153933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted and dynamic contrast-enhanced MRI of prostate cancer: correlation of quantitative MR parameters with Gleason score and tumor angiogenesis.
    Oto A; Yang C; Kayhan A; Tretiakova M; Antic T; Schmid-Tannwald C; Eggener S; Karczmar GS; Stadler WM
    AJR Am J Roentgenol; 2011 Dec; 197(6):1382-90. PubMed ID: 22109293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IMPROD biparametric MRI in men with a clinical suspicion of prostate cancer (IMPROD Trial): Sensitivity for prostate cancer detection in correlation with whole-mount prostatectomy sections and implications for focal therapy.
    Merisaari H; Jambor I; Ettala O; Boström PJ; Montoya Perez I; Verho J; Kiviniemi A; Syvänen K; Kähkönen E; Eklund L; Pahikkala T; Vainio P; Saunavaara J; Aronen HJ; Taimen P
    J Magn Reson Imaging; 2019 Nov; 50(5):1641-1650. PubMed ID: 30903647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined
    Elschot M; Selnæs KM; Sandsmark E; Krüger-Stokke B; Størkersen Ø; Giskeødegård GF; Tessem MB; Moestue SA; Bertilsson H; Bathen TF
    J Nucl Med; 2018 May; 59(5):762-768. PubMed ID: 28986510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apparent Diffusion Coefficient Values of the Benign Central Zone of the Prostate: Comparison With Low- and High-Grade Prostate Cancer.
    Gupta RT; Kauffman CR; Garcia-Reyes K; Palmeri ML; Madden JF; Polascik TJ; Rosenkrantz AB
    AJR Am J Roentgenol; 2015 Aug; 205(2):331-6. PubMed ID: 26204283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periprostatic fat thickness on MRI: correlation with Gleason score in prostate cancer.
    Woo S; Cho JY; Kim SY; Kim SH
    AJR Am J Roentgenol; 2015 Jan; 204(1):W43-7. PubMed ID: 25539273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiparametric Magnetic Resonance Imaging for Discriminating Low-Grade From High-Grade Prostate Cancer.
    Vos EK; Kobus T; Litjens GJ; Hambrock T; Hulsbergen-van de Kaa CA; Barentsz JO; Maas MC; Scheenen TW
    Invest Radiol; 2015 Aug; 50(8):490-7. PubMed ID: 25867656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying in vivo DCE MRI markers associated with microvessel architecture and gleason grades of prostate cancer.
    Singanamalli A; Rusu M; Sparks RE; Shih NN; Ziober A; Wang LP; Tomaszewski J; Rosen M; Feldman M; Madabhushi A
    J Magn Reson Imaging; 2016 Jan; 43(1):149-58. PubMed ID: 26110513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance imaging-transectal ultrasound image-fusion biopsies accurately characterize the index tumor: correlation with step-sectioned radical prostatectomy specimens in 135 patients.
    Baco E; Ukimura O; Rud E; Vlatkovic L; Svindland A; Aron M; Palmer S; Matsugasumi T; Marien A; Bernhard JC; Rewcastle JC; Eggesbø HB; Gill IS
    Eur Urol; 2015 Apr; 67(4):787-94. PubMed ID: 25240973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fusion of Magnetic Resonance Imaging and Real-Time Elastography to Visualize Prostate Cancer: A Prospective Analysis using Whole Mount Sections after Radical Prostatectomy.
    Brock M; Roghmann F; Sonntag C; Sommerer F; Tian Z; Löppenberg B; Palisaar RJ; Noldus J; Hanske J; von Bodman C
    Ultraschall Med; 2015 Aug; 36(4):355-61. PubMed ID: 24854132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of Detected and Missed Prostate Cancer Foci on 3-T Multiparametric MRI Using an Endorectal Coil Correlated With Whole-Mount Thin-Section Histopathology.
    Tan N; Margolis DJ; Lu DY; King KG; Huang J; Reiter RE; Raman SS
    AJR Am J Roentgenol; 2015 Jul; 205(1):W87-92. PubMed ID: 26102423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.